NOFO: OTPP-3

Print
NOFO Table of Contents

About the NOFO

The NOFO has a total of 11 sections.

Section A describes information about the program, including the scope of services and funding information.
Section B describes eligibility criteria and restrictions.
Section C describes program details, including its purpose, priorities, and relevant statutes and regulations.
Section D includes details on the required content and format for the application.
Section E describes how to submit the application materials and registration requirements.
Section F details the review and risk assessment process and criteria.
Section G describes the notification process.
Section H details requirements for subrecipient organizations after they have been awarded.
Section I includes information relevant to the application, including technical assistance and relevant definitions.
Section J lists mandatory forms for submission.
Section K consists of citations found throughout the funding notices.

A. Basic Information

This Notice of Funding Opportunity (NOFO) sets forth the requirements for program applications to fund.

A.1. Executive Summary

This new Notice of Funding Opportunity (NOFO) sets forth the requirements for applications to establish Opioid Treatment Program Partnerships (OTPP-3) programs in Illinois. This funding opportunity is limited to services delivered to and within the following Illinois Department of Public Health (IDPH) regions: West Chicago, Peoria, Champaign, and Metro East. The goal of OTPP-3 is to increase access to all forms of medication-assisted recovery (MAR) throughout Illinois for people with opioid use disorder (OUD) or polysubstance use disorder (including opioids), focusing on disparately impacted populations. MAR is the use of Food and Drug Administration (FDA)-approved medications to treat substance use disorder. Currently, medications approved to treat OUD include methadone, buprenorphine, and naltrexone.

OTPP-3 will reach this goal through the following objectives:

  • Forge partnerships between opioid treatment programs (OTPs) and federally qualified health centers (FQHCs), hospitals, clinics, or public departments of health.
  • Establish new OTPs, or new satellite OTP locations of existing OTPs within the sites of their medical partners, in regions of the state not currently served adequately by existing OTPs and medication units (“MAR deserts”).
  • Create collaborative care models supported by these partnerships to ensure patients have access to comprehensive substance use disorder (SUD) services, including physical (medical), behavioral health, and recovery support services (42 CFR § 8.2).

To accomplish these objectives, subrecipients of OTPP-3 funding will:

  • Establish and maintain a partnership with at least one medical partner: an FQHC, hospital, clinic, or public department of health.
  • Obtain and maintain the credentials required to dispense methadone at the approved location, and to provide the other FDA-approved medications for OUD, within one (1) year of the start of the period of performance; obtain accreditation and standard SAMHSA certification within one (1) year after SAMHSA provisional certification (see Task 2.3 in Section C.3).
  • For a new OTP or a new satellite location, secure and build out the site and conduct community relations activities.
  • Provide collaborative medical and behavioral health care and coordinate services with the medical partner.
  • Accept people who receive Medicaid or Medicare and people who are uninsured.

Up to four (4) organizations will be awarded funds to fulfill the requirements of the subaward.

Services provided under this NOFO shall reflect the Illinois Department of Human Services’ (IDHS) commitment to advancing equity and racial and social justice by enabling all to thrive, regardless of race, ZIP Code, or disability.

A.2. Funding Information

  • All materials, links, and resources related to this NOFO are available at the Illinois Regional Care Coordination Agency (RCCA) website via the Funding Opportunities page.
  • This is a new competitive subaward opportunity.
  • The release of this NOFO does not obligate IDHS or the RCCA to make an award.
  • The source of funding for this program is the Illinois Opioid Remediation State Trust Fund.
  • Applicants with existing IDHS awards are eligible to compete with applications for new state awards. However, funds received under one award generally cannot be used for another, even if the public services are the same or similar. See 2 CFR § 200.405(c).

Available Funding

  • The total amount of funds available for the OTPP program is estimated to be $9,600,000 to be awarded over three (3) years. An initial round (OTPP) was awarded in 2025 to three subrecipients, and an estimated $5,487,000 remains available for OTPP-3. Details are described in Section C.3. Scope of Services.
  • The RCCA anticipates awarding up to four (4) subawards of up to $457,000 per subawardee per budget year, prorated for the shorter first and last budget periods (see Section A.3., row q).

Periods of Performance

  • The period of performance means the total estimated time interval between the start of an initial award and the planned end date of the subaward agreement, which may include one or more funded portions, or budget periods. A period of performance does not include any subsequent renewals or options, which would create a new period of performance. Budget periods are aligned with the IDHS fiscal year. A period of performance may include one or more budget periods.
  • Funding for the initial period of performance is estimated to span from April 1, 2027 to June 30, 2028. Identification of the period of performance in this NOFO or in the subaward does not commit the State awarding agency to fund the award beyond the currently approved budget period. See 2 CFR § 200.1 and 44 Ill. Admin. Code 7000.30 (defining period of performance).

Budget Periods

  • Budget periods are not equivalent to the period of performance. Identification of the period of performance in this subaward does not commit IDHS or RCCA to fund the award.
  • If awarded, award amounts will be based on IDHS’ approval of the RCCA-approved applicant budget. Budgets must be sufficiently detailed, contain only allowable costs pursuant to 2 CFR Part 200, and be justified to be approved by the RCCA.

Renewals

  • Subrecipients may be eligible to receive up to two (2) subsequent grant renewals for this program within the three-year award cycle.
  • The initial period of performance is anticipated to end on June 30, 2028. If the subaward agreement is renewed, the period of performance is anticipated to continue from July 1, 2028, through June 30, 2029, and, if renewed again, from July 1, 2029, through March 31, 2030, unless the agreement is terminated, appropriations are no longer available, or for any other termination reason allowed by the State.
  • The execution of a subaward agreement shall not create any expectation of a subaward renewal. Renewals at the completion of the period of performance specified in the subaward agreement of this program are at the discretion of the RCCA and IDHS, based on performance and sufficient appropriations. Continued funding is subject to funding appropriations and release of funds by IDHS.

Continuation of Funding

  • Continuation of funding following completion of the three-year award cycle is not automatic or guaranteed. Subrecipients who have completed a three-year award cycle must submit a new application for any new NOFOs to be considered for future funding.
  • Grant funds that are not expended or legally obligated must be returned within the time period stated in the award.
  • Applicants should be aware that a new award will require compliance with all terms and conditions of the new subaward agreement, which may differ from prior agreements. The ability to perform work under the previous award does not guarantee eligibility or selection for the new award. All applications will undergo an eligibility review.

A.3. Summary Table

Row Field Value
a Funding Opportunity Title Opioid Treatment Program Partnerships (OTPP-3)
b Funding Opportunity Number O-24-OTPP3-26
c Awarding Entity RCCA as established by IDHS (Catalog of State Financial Assistance 444-42-3916)
d Announcement Type NOFO Announcement (Subaward)
e Posting Date November 18, 2026
f Period Application Open 58 days
g Questions Submission Due Date January 4, 2027, by 5:00 p.m. CT
h Application Closing Date and Time January 15, 2027, at 5:00 p.m. CT
i Anticipated Notification Date February 18, 2027
j Anticipated PoP Begin Date April 1, 2027
k Contact Randi Moberly, Ph.D. · 312-386-7505 · OTPP-3 Applicant Contact Form
l Average Prior Award $457,000 per budget year (three OTPP awards made in 2025)
m Source of Funding Illinois Opioid Remediation State Trust Fund
n Estimated Total Program Funding $9,600,000 over three (3) years ($3,200,000 per year) for the OTPP program; an estimated $5,487,000 remains available for OTPP-3
o Anticipated Number of Awards Up to four (4)
p Funding Periods Four (4) budget periods (BP) are associated with this award. Subrecipients may be eligible to receive up to two (2) subsequent grant renewals for this program, depending upon the availability of funds. Renewals are at the discretion of the RCCA and IDHS, based on performance and sufficient appropriations. The anticipated funding periods for this award are as follows:

Period of Performance 1: BP1, April 1, 2027, through June 30, 2027; BP2, July 1, 2027, through June 30, 2028

Period of Performance 2: BP3, July 1, 2028, through June 30, 2029

Period of Performance 3: BP4, July 1, 2029, through March 31, 2030

q Funding per Period of Performance Subject to the conditions of row p above, the allocated funding per budget year is up to $457,000 per award: up to $114,250 for BP1 (three months), $457,000 each for BP2 and BP3, and $342,750 for BP4 (nine months). See Section A.2. for additional details.
r Cost-Sharing or Matching Requirement No
s Indirect Costs Allowed Yes, but not required
t Restrictions on Indirect Costs Indirect costs are allowed. Indirect Cost Rate must be approved. See Section C.5. Funding Details. Also see restrictions to indirect costs in accordance with the appropriate sections of 44 Ill. Admin. Code Part 7000 and 2 CFR Part 200. All subrecipients, excluding local educational agencies (as defined in 34 CFR § 77.1) must make an indirect cost election during the application process: 1) Negotiated indirect cost rate agreement (NICRA); 2) De minimis; 3) No rate (all budgeted costs are direct costs).

Note: Release of this NOFO does not obligate the RCCA or IDHS to make an award.

B. Eligibility

B.1. Eligible Applicants

OTPP-3 is open to opioid treatment programs (OTPs), new or existing, that propose to deliver services through one of the three models described in Section C.3.

This competitive funding opportunity is limited to applicants that meet the following requirements:

  • Applicants must be a nonprofit, for-profit, or tax-exempt entity qualified to do business with the State of Illinois.
  • Applicants must be able to fulfill the scope of services detailed in this funding notice.
  • Applicants must have the capacity to comply with the legal, fiscal, reporting, and programmatic requirements as described in this funding notice.
  • Applicants proposing the use of program funds to provide services that require state or federal licensure must be actively licensed or in the process of licensure, must hold all applicable licenses within one (1) year of the start of the period of performance, as described in Sections C.3 and C.4, must hold each required license before starting the services that require it, and must ensure all staff have appropriate credentials.
  • The applicant must be an opioid treatment program (OTP), new or existing, that is licensed by IDHS/DBHR to provide methadone or is in the process of licensure.
  • The applicant must have a developed or developing partnership with at least one medical partner: a federally qualified health center, hospital, clinic, or public department of health.
  • Services must be delivered in the West Chicago, Peoria, Champaign, or Metro East IDPH region through one of three models: (1) a new OTP; (2) an existing OTP starting a new satellite OTP location within its medical partner’s site; or (3) an existing OTP establishing a new partnership with a medical partner, meaning the OTP had no memorandum of understanding or partnership agreement with that partner on November 18, 2026.
  • An existing OTP expanding services at its current location without a new medical partnership is not eligible. Mobile units are not eligible under this NOFO; they are funded through the MMHU program.

A nonprofit, for-profit, or tax-exempt entity may only submit one application under this funding opportunity. For example, multiple individuals in one organization cannot submit multiple applications; a parent company cannot submit an application, and a subsidiary cannot submit a second application for the same funding opportunity.

Cost sharing is not required.

C. Program Description

C.1. Background

In 2013, 1,072 people in Illinois died of an opioid overdose; by 2023, this number had more than doubled to 2,855. To hold companies responsible for their roles in the opioid crisis, the Illinois Attorney General has engaged in multiple investigations, lawsuits, and settlements with opioid manufacturers, distributors, and chain pharmacies. The funds from the settlements will support recovery in communities hardest hit by the opioid crisis and throughout the state.

The Illinois Office of Opioid Settlement Administration (OOSA) is the entity responsible for planning, administering, and managing fifty-five percent (55%) of the funds received from opioid settlements according to the Illinois Opioid Allocation Agreement and Executive Order 2022-19. The established processes ensure transparency and consideration of regional needs such as overdose rates, disparities created for specific populations, and resources to address opioid-related harms. OOSA is housed within IDHS DBHR.

About IDHS/DBHR

The mission of IDHS/DBHR is to advance health and wellness for all people of Illinois through a comprehensive system of prevention, treatment, harm reduction, and recovery services. DBHR is responsible for ensuring that children, adolescents, and adults throughout Illinois have access to comprehensive substance use and mental health services. DBHR operates a statewide system that supports prevention, intervention, treatment, harm reduction, and recovery services for individuals, families, and communities through a combination of State and Federal funding. The system includes community-based mental health and substance use services delivered through partners and inpatient mental health services through twenty-seven (27) community hospitals with psychiatric units and seven (7) state-operated hospitals. DBHR is also responsible for regulating all substance use intervention and treatment providers in the State of Illinois to ensure safety and quality of care.

DBHR focuses on improving outcomes, expanding access to care, reducing stigma, and providing coordinated care for people with behavioral health needs. It aims to create a more connected, responsive, and effective system of care through partnership with communities and providers.

Funding Source

The Office of the Illinois Attorney General has certified—and the Governor’s Opioid Prevention and Recovery Steering Committee has approved—the use of up to an estimated $9,600,000 over three (3) years from the Illinois Opioid Remediation State Trust Fund (Fund) to establish Opioid Treatment Program Partnership (OTPP) programs in accordance with the Illinois Opioid Allocation Agreement and the Fund allocation process.

An initial round (OTPP) was awarded in 2025 to three subrecipients. OTPP-3 is the next round of this program. An estimated $5,487,000 remains available for OTPP-3.

In April 2023, IDHS/DBHR awarded Advocates for Human Potential, Inc. (AHP) a grant to serve as the RCCA. Effective July 1, 2026, IDHS/DBHR awarded AHP a new grant agreement to continue serving as the RCCA. The RCCA administers subawards with organizations providing prevention, intervention, treatment, and harm reduction services for people with SUDs in accordance with state-approved strategies and the scope of services provided by IDHS.

C.2. Need

The funds from the settlements will support prevention efforts in communities hit hardest by the opioid crisis and throughout the state. Under the Illinois Opioid Allocation Agreement, funds disbursed from the Illinois Remediation Fund must support the approved abatement uses listed in the Agreement and must provide services in each of the state’s seven regions. Resources must be allocated equitably across those regions, taking into consideration population and other factors relevant to opioid abatement, including rates of opioid use disorder, overdose deaths, and the amount of opioids shipped into each region as measured in morphine milligram equivalents.

Generally, opioid settlement funding must be used in service areas disproportionately affected by the opioid crisis, such as areas with the following characteristics:

  • High opioid fatality rates, including: counties other than Cook County with a crude rate of one and eight tenths (1.8) or greater per one hundred thousand (100,000) people; and community areas within Cook County with more than one hundred (100) overdoses (fatal and nonfatal) within the most recent year included in the Chicago Health Atlas’ drug overdose mortality rate dashboard.
  • Concentrated poverty, including: counties other than Cook County with a poverty rate greater than twelve percent (12%); and community areas within Cook County with a poverty rate greater than twelve percent (12%), per the Chicago Health Atlas’ poverty rate dashboard.
  • Concentrated firearm violence, including communities eligible for Reimagine Public Safety Act funding.
  • Other conditions that hinder the communities from reaching their full potential for health and well-being, including counties other than Cook with a crude nonfatal overdose rate of four (4.0) or greater per one hundred thousand (100,000) people, as listed in the Illinois Overdose Data Dashboard.

Specifically, for OTPP-3, services must be delivered in the West Chicago, Peoria, Champaign, or Metro East IDPH region.

MAR is the use of medications in conjunction with behavioral therapies to treat substance use disorders. FDA-approved medications for OUD include buprenorphine, methadone, and naltrexone (CDC, n.d.). These medications have been shown to reduce the risk of overdose, use of emergency medical services, and mortality (Wakeman et al., 2020) and to improve outcomes such as retention in treatment (Timko et al., 2016) and maternal and fetal outcomes for pregnant and parenting people (American College of Obstetricians and Gynecologists, 2017).

However, even though they are recommended as the standard of care, these medications remain underutilized due to stigma and lack of access (D’Arrigo, 2019). Methadone for OUD can be dispensed only by federally certified OTPs. As of the release of the March 2022 Overdose Response Funding report, IDHS identified 39 counties with no MAR providers located within the counties’ geographic boundaries. SAMHSA maintains an up-to-date Opioid Treatment Program Directory, which can be filtered by state.

Partnerships between OTPs and healthcare facilities that provide physical (medical), behavioral health, and recovery support services to people with OUD can facilitate more equitable access to life-saving methadone and other OUD medications, while simultaneously connecting them to services that address social determinants of health.

OTPP-3 services must be delivered in the West Chicago, Peoria, Champaign, or Metro East IDPH region. Within these regions, OTPP-3 prioritizes MAR deserts and people who receive Medicaid or Medicare or are uninsured. Proposals are also considered in light of overdose data in the proposed area, the current unavailability of OTP services, the availability of other MAR and SUD services, and outreach to disparately impacted populations.

C.3. Funding Purpose and Scope of Services

Advocates for Human Potential, Inc. (AHP) anticipates that up to four (4) organizations will be awarded funding to increase access to all forms of MAR throughout Illinois for people with OUD or polysubstance use disorder (including opioids), focusing on disparately impacted populations. This goal shall be accomplished through the following objectives:

  • Forge partnerships between opioid treatment programs (OTPs) and federally qualified health centers (FQHCs), hospitals, clinics, or public departments of health.
  • Establish new OTPs, or new satellite OTP locations of existing OTPs within the sites of their medical partners, in MAR deserts within the West Chicago, Peoria, Champaign, or Metro East IDPH region.
  • Create collaborative care models supported by these partnerships to ensure patients have access to comprehensive substance use disorder (SUD) services, including physical (medical), behavioral health, and recovery support services (42 CFR § 8.2).

To carry out these objectives, OTPP-3 subrecipients shall:

  • Establish and maintain a partnership with at least one medical partner: an FQHC, hospital, clinic, or public department of health.
  • Obtain and maintain the credentials required to dispense methadone at the approved location, and to provide the other FDA-approved medications for OUD, within one (1) year of the start of the period of performance; obtain accreditation and standard SAMHSA certification within one (1) year after SAMHSA provisional certification (see Task 2.3 in Section C.3).
  • For a new OTP or a new satellite location, secure and build out the site and conduct community relations activities.
  • Provide collaborative medical and behavioral health care and coordinate services with the medical partner.
  • Accept people who receive Medicaid or Medicare and people who are uninsured.

Approach

The Subrecipient shall increase access to all forms of MAR for people with OUD or polysubstance use disorder by forging a partnership between an OTP and a medical partner (an FQHC, hospital, clinic, or public department of health) and by establishing new OTP capacity in MAR deserts within the West Chicago, Peoria, Champaign, or Metro East IDPH region. Services shall be delivered through a collaborative medical and behavioral health care model that provides all FDA-approved medications for OUD, delivered by appropriately licensed, certified, and credentialed staff, and shall accept people who receive Medicaid or Medicare and people who are uninsured.

Proposals can be for (1) a new OTP with a developed or developing partnership with a medical partner, including an existing treatment location that does not dispense methadone today, such as one that prescribes buprenorphine; (2) an existing OTP that starts a new satellite OTP location within its medical partner’s site; or (3) an existing OTP that establishes a new partnership with a medical partner to provide collaborative care. A partnership is new if the OTP had no memorandum of understanding or partnership agreement with that medical partner on November 18, 2026. An existing OTP expanding services at its current location without a new medical partnership is not eligible. Mobile units are funded through the MMHU program. Every Subrecipient opening a new OTP or a new satellite location (models 1 and 2) must complete Tasks 2.4 and 2.5 (site development and community relations) and obtain all credentials for that location within one (1) year of the start of the period of performance (see Task 2.3); zoning documentation is required where applicable.

Of the three (3) years of potential funding, startup expenses will be allocated for the first year only. Additional startup expenses may be considered for organizations that have not completed the regulatory process within the first award year, but a failure to meet deliverable timelines will be reviewed as part of a Subrecipient’s performance, and funding beyond the first year of the award is not guaranteed.

All Subrecipients are required to obtain and maintain the following:

  • Accreditation by a SAMHSA-approved accreditation body
  • Certification by SAMHSA in accordance with 42 CFR Part 8, Subpart C
  • Registration with the Drug Enforcement Administration (DEA)
  • Licensing by IDHS/DBHR

Geographic Service Area

Services must be delivered to and within the West Chicago, Peoria, Champaign, and Metro East IDPH regions.

Standards and Evidence-Based Practices

The Subrecipient shall deliver services in accordance with the following standards of practice:

  • Federal opioid treatment standards: Operate as a certified OTP meeting the federal opioid treatment standards at 42 CFR Part 8, including program sponsor and medical director, patient admission, medication dosing and unsupervised-use determinations, physical examinations, drug testing, and diversion control.
  • SAMHSA certification and accreditation: Hold or obtain SAMHSA OTP certification and accreditation by a SAMHSA-approved accrediting body.
  • DEA registration: Register the program and each location with the DEA and submit to inspection.
  • State SUD licensure: Hold IDHS/DBHR licensure for the applicable American Society of Addiction Medicine (ASAM) level of care and deliver treatment in accordance with the Substance Use Disorder Act (20 ILCS 301) and 77 Ill. Admin. Code Part 2060.
  • Interoperable electronic health record: Use an electronic health record (EHR) certified by the Office of the National Coordinator for Health Information Technology (ONC) that is interoperable with the medical partner’s system.
  • FDA-approved medication for OUD: Provide all FDA-approved medications for opioid use disorder (MOUD), methadone, buprenorphine, and naltrexone, collectively across the partnership.
  • Low-barrier access: Prefer same-day admission and medication access and expedite services for high-risk groups.
  • Coverage acceptance: Accept participants who receive Medicaid or Medicare and participants who are uninsured.

The required tasks, organized by phase as in the RCCA Statement of Work, are as follows. Associated performance measures, standards, and potential metrics to be collected are detailed in Section C.4.

Phase 1: Initiation

Task 1.1 Award Activation and Onboarding

The Subrecipient shall complete all steps required to formally activate the award and complete RCCA onboarding.

Task 1.2 Implementation and Sustainability Plan (ISP) Submission

The Subrecipient shall submit an ISP using the current RCCA-provided template. The ISP is the program plan describing how the Subrecipient will deliver the program. It is supported by an ISP Data Workbook that establishes the approved delivery and performance baseline, including what will be delivered, in what volume, and how performance will be measured.

The ISP also includes the Subrecipient’s Equity and Racial Justice (ERJ) self-assessment and preliminary equity and racial justice approach. These are components of the ISP and are not separately submitted; they inform the complete ERJ Plan required in Phase 2.

Phase 2: Development

Task 2.1 Program-Specific Readiness Requirements

The Subrecipient shall establish the following program-specific readiness requirements needed to begin program delivery. Each requirement is established prior to the start of program delivery and maintained throughout the Period of Performance, except where a requirement states otherwise. Readiness status is described in the ISP under Task 1.2; the deliverables below are satisfied by the underlying documentation, not by the ISP submission itself.

For OTPP-3, the program-specific readiness requirements are the following:

  • Licenses, registrations, certifications, and credentials required for the approved service model, other than the OTP credentials addressed in Task 2.3
  • Program staffing in accordance with the approved staffing plan and Budget, including designated program leadership, a medical director, and a program sponsor who fulfill the responsibilities in 42 CFR § 8.12
  • The data systems, records, and collection processes required to produce the DPR and other RCCA-prescribed reporting

Task 2.2 (Medical Partnership) and Task 2.3 (OTP Credentialing) apply to every Subrecipient. Task 2.4 (Site Development: New Location) and Task 2.5 (Community Relations and Engagement: New Location) apply to a Subrecipient opening a new OTP or a new satellite location (models 1 and 2). Task 2.6 (Equity and Racial Justice Plan) applies to every Subrecipient.

Task 2.2 Medical Partnership

The Subrecipient shall establish and maintain a memorandum of understanding (MOU) or partnership agreement with at least one medical partner, through which participants receive physical health services alongside MOUD. The MOU shall describe how the OTP and its medical partner(s) meet the following requirements:

  • The OTP and its medical partner(s) collectively provide all FDA-approved medications for OUD (methadone, buprenorphine, buprenorphine/naloxone, and intramuscular [IM] naltrexone). Providing a medication includes dispensing it; under 42 CFR § 8.2, dispensing includes prescribing and administering (see Section I.2).
  • The OTP provides all medications unless the medical partner can provide buprenorphine, buprenorphine/naloxone, and IM naltrexone.
  • All patients are counseled on all medication options.
  • All parties counsel patients on harm reduction, including prescribing or dispensing naloxone.
  • Individuals who do not meet criteria for treatment are offered, preferably via warm handoff, connections to harm reduction and recovery support services.

The MOU shall specify which party is responsible for meeting the requirements of 42 CFR Part 8, and in particular 42 CFR § 8.12, in a manner consistent with all applicable state and federal regulations.

Task 2.3 OTP Credentialing

The Subrecipient and its medical partner shall obtain and maintain the licenses, certifications, accreditations, and registrations required to operate an OTP and dispense MOUD at the approved location, including IDHS/DBHR licensing to provide ASAM Level 1 services, SAMHSA certification, accreditation by a SAMHSA-approved body, Medicaid certification, and DEA registration. These requirements arise under federal and state law independently of this award. As applicable to the approved model, the Subrecipient shall submit its IDHS/DBHR license, DEA registration, SAMHSA certification, and accreditation applications together once the site is secured and the medical director is named, and no later than Day 180. Within one (1) year of the start of the period of performance, the Subrecipient shall hold the credentials needed to dispense methadone at the approved location (IDHS/DBHR licensure and methadone authorization, DEA registration, and SAMHSA provisional certification, with accreditation applied for) and the credentials needed to provide buprenorphine, buprenorphine/naloxone, and IM naltrexone. The Subrecipient shall obtain accreditation and standard SAMHSA certification within one (1) year after SAMHSA provisional certification (see 42 CFR § 8.11(d) and 77 Ill. Adm. Code 2060.420(g)(1)). The Subrecipient shall report its progress in each DPR until all credentials are held. If delays outside the Subrecipient’s control prevent it from meeting these deadlines, the RCCA may consider extending them into a second year. Subrecipients seeking to offer MAR services at a new location, or at an existing treatment location not approved for dispensing methadone, may include the cost of obtaining new credentials in their proposed budget.

As a requirement of certification, the Subrecipient shall develop a Diversion Control Plan as part of its quality assurance program (42 CFR § 8.12(c)) and patient admission criteria aligned with 42 CFR § 8.12(e). Per 42 CFR § 8.12(b)(2), the medical director is responsible for ensuring that the Subrecipient and its medical partner(s) collectively comply with all applicable federal, state, and local laws and regulations related to OTPs.

Task 2.4 Site Development: New Location

This task applies to a Subrecipient opening a new OTP or a new satellite location (models 1 and 2). The Subrecipient shall secure and prepare an appropriate location for MAR services, including the following:

  • Site control: Establish control of the site through a contract of sale, lease agreement, binding option to lease or purchase, or MOU with the medical partner.
  • Local zoning: Comply with all applicable local zoning regulations before establishing MAR services, where applicable.
  • Site build-out: Meet all state and federal requirements, including client privacy and secure storage of medications, and obtain an architect’s Life Safety Inspection and Report.
  • Technology: Install an ONC-certified EHR that is interoperable with the EHR of any partner designated to provide health or dental services to OTP participants.
Task 2.5 Community Relations and Engagement: New Location

This task applies to a Subrecipient opening a new OTP or a new satellite location (models 1 and 2). The Subrecipient shall develop and follow a Community Relations Plan that identifies community leaders (for example, elected officials, business owners, law enforcement, the faith community, and grassroots organizations), points of contact within the OTP and the community, communications protocols, and opportunities for paid work experiences that expand the local workforce.

The Subrecipient shall hold community listening sessions in the neighborhood where the OTP or satellite location will be located, to build relationships among local interest-holders, reduce stigma, identify potential concerns, and gather information on local needs. The Subrecipient shall then develop community relations policies and procedures consistent with CARF International’s Community Relations Tips for Opioid Treatment Programs, addressing at minimum maintaining the exterior and grounds, preventing loitering, preventing medication diversion, minimizing traffic disruptions, and complaint intake and response.

Task 2.6 Equity and Racial Justice Plan

The Subrecipient shall develop and implement an Equity and Racial Justice (ERJ) approach that reflects IDHS’s commitment to advancing equity and racial and social justice. The ERJ self-assessment and preliminary equity approach are developed through the ISP under Task 1.2 and are not separately submitted. Building on them, the Subrecipient shall submit a complete ERJ Plan that identifies and addresses implicit organizational bias, ensures equitable access to and outcomes from OTP services and the collaborative model of care, engages priority populations and the communities served, and includes an equity and racial justice training plan for program staff. Implementation progress, barriers, and disaggregated results are reported through each PPR.

Phase 3: Implementation

The service categories below constitute the required program scope. The Subrecipient shall deliver each service category throughout the period of performance in accordance with the scope of services, the approved ISP, and the approved ISP Data Workbook.

Task 3.1 Collaborative Medical and Behavioral Health Care

The Subrecipient and its medical partner(s), under the direction of the Program Director, shall provide collaborative medical and behavioral health care in accordance with the partnership MOU and all applicable state and federal regulations. The Subrecipient shall maintain privacy and confidentiality (42 CFR § 8.12(g)); dispense only FDA-approved medications for the treatment of OUD (42 CFR § 8.12(h)); and provide low-barrier access to medication, with same-day admission and medication access preferred and expedited services for high-risk groups (individuals experiencing homelessness, justice-involved individuals, and pregnant or postpartum persons). The Subrecipient shall offer counseling but shall not condition access to MOUD on participation in counseling (42 CFR § 8.12(f)(5)).

Task 3.2 Coordination of Services

The Subrecipient and its medical partner(s) shall conduct coordination of services activities, holding regular case conferences or using other methods, in person or virtually, to coordinate care for OTP clients.

Task 3.3 Transportation Services (Optional)

Where elected and approved in the ISP, the Subrecipient may provide limited transportation services to ensure OTP clients receive medical care from the Subrecipient’s medical partners, either through a shuttle service on designated days or through ad hoc support such as transit passes or taxi vouchers, and shall counsel individuals about transportation options (such as paratransit) for which they may be eligible.

Phase 4: Monitoring

Task 4.1 Performance and Fiscal Reporting

The Subrecipient shall complete all recurring performance, delivery, and fiscal reporting on the State Fiscal Year (FY) calendar through the RCCA-prescribed system. Invoices are due monthly, by the 15th of the following month; DPRs are due monthly, by the 15th following the close of the reporting period; PPRs and PFRs are due quarterly, by the 20th after each State Fiscal Year quarter ends. The monthly Invoice is RCCA’s monthly financial report under the prime award and also serves as the payment request.

Each PPR addresses, as applicable, staffing, service-model implementation, policies and procedures, Equity and Racial Justice (ERJ) and sustainability activities, material changes, implementation barriers, and corrective or continuous-improvement actions.

For OTPP-3, because OTP credentialing and site build-out may extend into the period of performance, DPR service-delivery reporting for a new location begins with the first full reporting month after services are initiated at that location. Invoices are due monthly beginning at award.

Task 4.2 Staffing Maintenance

The Subrecipient shall ensure that required personnel and staffing remain in place throughout the Period of Performance, including designated program leadership. Staffing shall remain consistent with the approved staffing plan, the approved Budget, and the program model. Staffing status shall be reported through the PPR.

C.4. Deliverables and Performance Measures

The tables below list, by task, (a) the deliverables required under the scope of services and (b) the associated performance measures, standards, and potential metrics to be collected.

NOTE: Unless otherwise specified, time periods count days from the start of the Period of Performance. Standards for activities refer to percentages of those established in the approved ISP Data Workbook.

Phase 1: Initiation

Task 1.1 Award Activation and Onboarding
Performance Measures Standards Metrics
(a) Attend the RCCA kickoff meeting (Program Director plus at least one program staff). 100% Day 30
(b) Submit organizational chart with all budgeted positions, names or TBH designations, FTE allocations, and reporting lines. 100% Day 60
(c) Complete RCCA onboarding TTA (Program Director or designee). 100% Day 75
Task 1.2 Implementation and Sustainability Plan (ISP) Submission
Performance Measures Standards Metrics
(a) Submit ISP and ISP Data Workbook using the current RCCA template. 100% Day 90
(b) Incorporate any RCCA-required revisions. 100% Within 15 days of RCCA feedback
(c) Submit an ISP amendment for a material change. 100% Within 30 days of identifying the need for the change; the change may not take effect until RCCA approves the amendment

Note: If RCCA delays issuance of the applicable template or adjusts an administrative due date, RCCA may revise the submission deadline so the Subrecipient retains the intended preparation period.

Phase 2: Development

Task 2.1 Program-Specific Readiness Requirements
Performance Measures Standards Metrics
(a) Obtain all licenses, registrations, certifications, and credentials required for the approved service model (other than the OTP credentials addressed in Task 2.3), and submit evidence of each, or document through the ISP that none are required. 100% At least 30 days before service delivery begins
(b) Establish program staffing in accordance with the approved staffing plan and Budget, including designated program leadership, a medical director, and a program sponsor. ≥80% of the approved staffing plan At least 30 days before service delivery begins
(c) Establish the data systems, records, and collection processes required to produce the DPR and other RCCA-prescribed reporting. 100% At least 30 days before service delivery begins
Task 2.2 Medical Partnership
Performance Measures Standards Metrics
(a) Submit an executed MOU or partnership agreement with a medical partner, and submit new or materially updated agreements. 100% Day 120; updates within 30 calendar days of execution
(b) Where a partnership is still developing, submit a partnership development plan identifying the prospective partner or partners, the actions and dates required to reach an executed agreement, and the responsible staff. 100% Day 90
(c) Accept participants who have Medicaid or Medicare or who are uninsured. 100% Before service delivery begins; maintained ongoing
(d) Counsel all patients on all medication options, and counsel patients on harm reduction, including prescribing or dispensing naloxone. 100% Ongoing
(e) Report progress on the medical partnership and the delivery of physical health services to participants. 100% Through each PPR
Task 2.3 OTP Credentialing
Performance Measures Standards Metrics
(a) Identify each license, certification, accreditation, and registration required for the approved service model, the entity holding each, its current status, and the expected date for any not yet obtained. 100% Day 90, through the ISP
(b) Submit evidence of each credential obtained. 100% Within 30 calendar days of issuance
(c) Submit a Diversion Control Plan and patient admission criteria. 100% Within 60 days of IDHS/DBHR issuing a license to operate at the location
(d) Hold the credentials required to dispense MOUD at the approved location, including SAMHSA provisional certification with accreditation applied for. 100% Within one (1) year of the start of the Period of Performance (a second year may be considered for delays outside the Subrecipient’s control)
(e) Notify RCCA of any replacement of, or change in the status of, the program sponsor or medical director. 100% Within three (3) weeks of the change
(f) Submit the IDHS/DBHR license, DEA registration, SAMHSA certification, and accreditation applications, as applicable, and report progress in each DPR until all credentials are held. 100% Once the site is secured and the medical director is named, and no later than Day 180
(g) Obtain accreditation and standard SAMHSA certification. 100% Within one (1) year after SAMHSA provisional certification
Task 2.4 Site Development: New Location (models 1 and 2)
Performance Measures Standards Metrics
(a) Submit evidence of site control for the new location. 100% Day 90
(b) Submit a local certificate of zoning, or a signed statement that zoning approval is not applicable. 100% Day 90
(c) Complete site build-out and submit the architect’s Life Safety Inspection and Report. 100% Within one (1) year of the start of the Period of Performance
(d) Submit evidence of an ONC-certified EHR interoperable with the medical partner’s EHR. 100% Before administering MAR and within 30 days of IDHS/DBHR issuing a license to operate at the location
Task 2.5 Community Relations and Engagement: New Location (models 1 and 2)
Performance Measures Standards Metrics
(a) Submit the Community Relations Plan. 100% Day 60
(b) Conduct no fewer than three (3) community listening sessions. 100% Day 120
(c) Submit listening session documentation (date, location, attendance, concerns raised, and mitigation strategies discussed). 100% Day 150
(d) Submit community relations policies and procedures, including complaint intake and response. 100% Day 150
Task 2.6 Equity and Racial Justice Plan
Performance Measures Standards Metrics
(a) Submit the complete ERJ Plan. 100% Day 180
(b) Incorporate any RCCA-required revisions. 100% Within 15 days of RCCA feedback

Phase 3: Implementation

Task 3.1 Collaborative Medical and Behavioral Health Care
Performance Measures Standards Metrics
(a) Provide collaborative medical and behavioral health care. ≥80% of the approved objective to date Ongoing following service initiation; reported through each DPR
Task 3.2 Coordination of Services
Performance Measures Standards Metrics
(a) Coordinate OTP client services with the medical partner(s). ≥80% of the approved objective to date Ongoing following service initiation; reported through each DPR
Task 3.3 Transportation Services (Optional)
Performance Measures Standards Metrics
(a) Provide limited or ad hoc transportation to medical care, as elected in the ISP. ≥80% of the approved objective to date Ongoing; reported through each DPR

Phase 4: Monitoring

Task 4.1 Performance and Fiscal Reporting
Performance Measures Standards Metrics
(a) Submit Financial Reports (Invoices) in RCCA-prescribed format. 100% 15th day of the month following each reporting month *
(b) Submit Delivery and Performance Reports (DPRs) in RCCA-prescribed format. 100% Submitted monthly, by the 15th following the close of the reporting period *
(c) Submit Periodic Performance Reports (PPRs) in RCCA-prescribed format. 100% 20th day after each FY quarter end *
(d) Submit Periodic Financial Reports (PFRs) in RCCA-prescribed format. 100% 20th day after each FY quarter end *
(e) Cooperate with RCCA-designated program evaluation activities. 100% Throughout the Period of Performance, as prescribed
(f) Participate in RCCA-scheduled Project Status Meetings (PSMs). ≥75% Quarterly
(g) Participate in RCCA TTA Activities. ≥75% Onboarding TTA sessions (up to three (3)); cohort-focused TTA (as scheduled, up to quarterly); and TTA based upon performance needs or request (ad hoc).
(h) Submit the Performance Close-out Report. 100% Within 30 calendar days after the Period of Performance ends
(i) Submit the Financial Close-out Report and Final Invoice, and liquidate all obligations. 100% Within 45 calendar days after the Period of Performance ends

Note: If a due date falls on a weekend or holiday, the report is due the following business day.

Task 4.2 Staffing Maintenance
Performance Measures Standards Metrics
(a) Ensure required personnel and staffing remain in place, including designated program leadership. ≥80% of the approved staffing plan Ongoing; reported through each PPR

Program Performance Measures

Activity and output measures show what the program does and how many people it reaches. The Subrecipient reports them monthly through the DPR.

Measure Type Reporting frequency
Individuals served through OTPP-3, total and new Output Monthly through the DPR
Individuals initiated onto MOUD Output Monthly through the DPR
Individuals initiated onto MOUD, by medication Output Monthly through the DPR
Individuals receiving naloxone for overdose reversal at the OTP Output Monthly through the DPR
Individuals receiving harm reduction education or counseling Output Monthly through the DPR
Individuals receiving both MOUD and a physical examination or medical partner visit Output Monthly through the DPR

Outcome and utilization measures show the results of that work. RCCA calculates them from the activity and output measures and the objectives in the approved ISP Data Workbook and reviews them quarterly.

Measure Type Calculation
Medical integration rate Outcome Individuals receiving both MOUD and a physical examination or medical partner visit ÷ individuals initiated onto MOUD
Naloxone co-provision rate Outcome Individuals receiving naloxone for overdose reversal at the OTP ÷ individuals initiated onto MOUD
Treatment initiation rate Outcome Individuals initiated onto MOUD ÷ total individuals served through OTPP-3
New-participant share Outcome New individuals served ÷ total individuals served through OTPP-3
Harm reduction education reach Outcome Individuals receiving harm reduction education or counseling ÷ total individuals served through OTPP-3

C.5. Funding Details

The following sections discuss allowable and unallowable costs for this funding opportunity. Please refer to 2 CFR Part 200 – Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards, specifically 2 CFR Part 200 Subpart E – Cost Principles to determine the appropriateness of costs.

Allowable Costs

Allowable costs are those that are necessary and reasonable based on the activity contained in the statement of work (SOW), are justified in the Budget Narrative, and are allowable and allocable under 2 CFR §§ 200.400–476.

Specifically, “Allowable Cost” means a cost allowable to a project (i.e., that can be paid for using award funds). Costs will be considered to be allowable if they:

  • are reasonable and necessary for the performance of the award;
  • are allocable to the specific project;
  • are treated consistently in like circumstances to federally financed, State-financed, and other activities of the awardee;
  • conform to any limitations of the cost principles or the sponsored agreement;
  • are accorded consistent treatment (a cost may not be assigned to a State or federal award as a direct cost if any other cost incurred for the same purpose in like circumstances has been allocated to the award as an indirect cost);
  • are determined to be in accordance with generally accepted accounting principles;
  • are not included as a cost or used to meet federal cost-sharing or matching requirements of any other program in either the current or prior period;
  • are not used to meet the match requirements of another State or federal grant; and
  • are adequately documented.

It is expected that administrative costs, both direct and indirect, will represent a small portion of the overall program budget. Any budget deemed to include inappropriate or excessive administrative costs will not be approved. Program budgets and narratives must detail how all proposed expenditures are necessary for program implementation.

Unallowable Costs

Refer to 2 CFR Part 200 – Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards, and specifically 2 CFR Part 200 Subpart E – Cost Principles, to determine the appropriateness of costs.

Indirect Cost Rate

To charge indirect costs to this grant, the applicant organization must: (1) have a federal annually negotiated indirect cost rate agreement (NICRA), or (2) elect to use the de minimis rate and specify what percentage (up to fifteen percent 15% of modified total direct cost MTDC) the applicant chooses. See 2 CFR § 200.414.

Indirect Cost Rate Election

  • Federally Negotiated Rate: Organizations that receive direct federal funding may have an indirect cost rate that was negotiated with a federal cognizant agency. The organization must provide a copy of the federal NICRA. Organizations must notify the RCCA of any changes to their previously established NICRA no later than six (6) months after the close of the organization’s fiscal year.
  • De minimis Rate: An organization may elect a de minimis rate of up to fifteen percent (15%) of MTDC. Once established, the de minimis rate may be used indefinitely. If programs elect to use the de minimis rate, it is critical that program budgets accurately calculate the MTDC base.
  • “No Rate”: Subrecipients have discretion not to request payment for indirect costs. Subrecipients that elect not to claim indirect costs cannot be reimbursed for indirect costs. The organization must record an election of “No Indirect Costs” in the Budget Workbook link in Section J.1., Mandatory Forms.

C.6. Authorizing Statutes and Regulations

Subrecipients shall adhere to the requirements outlined in the following:

D. Application Contents and Format

The NOFO application is contained in an online fillable form, hosted by SurveyMonkey Apply. Applicants must have access to the internet. Use the application link to access the online application as early as possible to make sure you can log in. The link to the application is available at the IL RCCA website.

Instructions to complete the fillable form are included in the online application. You will be able to work on your online application, save your work, and return to it at your convenience. You may also add collaborators to assist with application development.

The individual submitting the application must attest within the application that they are authorized to submit the application on the organization’s behalf. All application submittals are final. Once the application is submitted, no further changes can be made.

You are responsible for ensuring that your application and all attachments have been successfully submitted in SurveyMonkey Apply, received by AHP, and submitted no later than the specified deadline in Section E.3. below and the Summary Table, row h.

Once the application is submitted, no further changes can be made.


You are responsible for ensuring that your application and all attachments have been successfully submitted in SurveyMonkey Apply, received by AHP, and submitted no later than the specified deadline in Section E.3 below and the Summary Table, row h.

 

D.1. Contents and Point Distribution

The online application includes seven (7) sections. Sections 1–2 contain information about your organization, including fiscal, administrative, and internal controls questions. Sections 1–2 are not scored as part of the merit-based review process but are used to fulfill prequalification and risk assessment criteria. Sections 3–7 are scored for a total of 100 possible points. Individual questions can be referenced on the NOFO Prepare to Apply page.

Please answer questions truthfully and completely. Be sure to cite the source of any data included.

Section Title Description Points
Section 1. Organization Information Basic administrative and fiscal information about your organization, including required attestations and attachments 0
Section 2. Fiscal and Internal Controls Administrative and management controls that inform the risk assessment that must be completed prior to Notice of Intent to Award (NOIA) 0
Section 3. Executive Summary An overview of your organization and the program you plan to deliver if awarded funding 2
Section 4. Need and Opportunity How the proposed work will contribute to the purpose of the program 30
Section 5. Experience and Capacity How your organization’s work, approach, and experience are aligned with the intent of the program requirements 30
Section 6. Quality The implementation approach and anticipated outcomes of the proposed activities to be funded by this notice 32
Section 7. Program Budget Program budget and advance payment request 6
100

D.2. Attachments

Applicants must submit the following files as attachments to the application. Those noted with an asterisk (*) are required. Files must be current and accurately reflect organizational information and practices.

# Item Description
A Conflict of Interest Disclosure* Discloses actual or potential conflicts of interest
B Form W-9* Verifies Taxpayer Identification Number
C Organizational Budget* Describes organizational revenues and expenditures for current fiscal year
D Organizational Chart* Describes the reporting structure and roles at the organization
E Single Federal Audit or Financial Statement Audit (if available) Provides assurance of internal controls to maintain grant compliance
F Approved NICRA (if applicable) Defines an organization’s federally negotiated indirect cost rate
G Financial Management and Personnel Policies and Procedures* Demonstrate financial management systems meet standards per 2 CFR § 200.302 and § 200.303. Applicants requesting advance payment must also include written procedures that minimize the time between receiving and disbursing funds (2 CFR § 200.305(b)).
H Letters of commitment* A signed letter of commitment from each partner organization named in application question 5.5, including the medical partner (file name prefix “H. Commitment”)
I Key personnel résumés or job descriptions* A résumé, CV, or job description for each key role, starting with the program sponsor and medical director (file name prefix “I. Key Personnel”)
J Letters of reference* Three letters of reference; two from previous grant funders are preferred (collected in application Section 1, file name prefix “J. Reference”)
K Program Plan* A detailed program plan for the proposed approach, including a month-by-month timeline (file name prefix “K. Program Plan”)

E. Submission Requirements and Deadline

The RCCA is now accepting applications to fund programs described in this NOFO. Applications will only be accepted through the online application available at the Illinois RCCA website via the Funding Opportunities page.

 

E.1. Application Availability

All application materials are available at the Illinois RCCA website on the Funding Opportunities page. Copies of all materials may be obtained by any of the following means:

  • Submit a request through the OTPP-3 Applicant Contact Form (the question form for this NOFO)
  • Call Randi Moberly at 312-386-7505
  • Mail a request for all application materials to: Advocates for Human Potential Regional Care Coordination Agency, 1021 West Adams Street, Suite 303, Chicago, IL 60607. Please note: You cannot submit your grant applications to this address. Applications will only be accepted online as described above.

E.2. Application Instructions

Under the Federal Uniform Guidance (2 CFR Part 200) and GATA (44 Ill. Admin. Code Sec. 7000.70(f)), all applicants must be qualified to receive an award. An eligible organization must:

  • Have an active System for Award Management (SAM.gov) public account
  • Have an active Unique Entity Identifier (UEI)
  • Not be on the SAM.gov Exclusion List
  • Be in good standing with the Illinois Secretary of State (if the Illinois Secretary of State requires the entity’s organization type to be registered; governmental entities, school districts, and select religious organizations are not required to be registered with the Illinois Secretary of State)
  • Not be on the Illinois Medicaid Sanctions List
  • Not be on the Illinois Stop Payment List
  • Must meet the other requirements listed in the certifications and representations section

If your organization does not meet these qualification requirements, your organization cannot receive funding for this award. Please take this into consideration before you take the time and effort to apply for this funding opportunity.

To obtain the information required to achieve qualified status, complete the steps detailed in the following table.

Step Requirement Link
1. Register with the State of Illinois Be actively registered with the Illinois Secretary of State. Illinois Secretary of State website
2. Obtain a Federal Employer Identification Number (FEIN/EIN) Obtain a FEIN/EIN from the Internal Revenue Service. FEIN/EIN application website
3. Register for a SAM.gov account and obtain a UEI. Register for and maintain an active SAM.gov account and obtain a 12-digit UEI. sam.gov

Applicants must complete the online application narrative questions and upload attachments as described herein. Detailed application questions and associated evaluation criteria are available at the IL RCCA website.

Attachments shall be PDF documents, except for the program budget, which is provided as an Excel workbook.

Mandatory forms, including the Budget Workbook and Conflict of Interest Disclosure, are linked in Section J. Mandatory Forms.

The applicant must develop a budget consistent with program requirements as described in Section C. Program Description and in accordance with Section F.2. Grant Funds Use Requirements.

E.3. Submission Dates and Times

The online application must be completed in full and submitted electronically in accordance with requirements defined at the IL RCCA website by January 15, 2027, at 5:00 p.m. CT. The deadline will be strictly enforced. Applications received after the due date and time will not be considered for review or funding.

It is the applicant’s sole responsibility to ensure that their entire application and any attachments have been successfully submitted and received. Upon submission, you will receive an email confirming receipt of your application. Please check your email and spam folder. In the event of technical difficulty during submission or if you do not receive a confirmation email within forty-eight (48) hours of your submittal, please submit a request through the OTPP-3 Applicant Contact Form.

 

E.4. Other Submission Requirements

None.

 

E.5. Submission Tips

The following steps are recommended to successfully submit this application.

Step Name Description
1 Review this document with your stakeholders. Does our organization meet all the applicant eligibility criteria? Is our organization able to effectively use these funds?
2 Prepare to apply. Identify who will work on different parts of the application. Develop a timeline for how to respond to the NOFO and submit on time.
3 Access technical assistance resources. Register for the Technical Assistance session. Ask questions and review answers submitted by others.
4 Complete attachments and forms. Download and complete the budget workbook. Download and complete the IDHS Conflict of Interest form. Complete all other attachments.
5 Complete the online application. Complete all sections of the online application. Upload all required and applicable attachments. Review and submit. Once submitted, no changes may be made.
6 Get help with technical problems. If you have trouble accessing, completing, or submitting the online application, contact the RCCA before the application deadline: submit a request through the OTPP-3 Applicant Contact Form or call Randi Moberly at 312-386-7505. If you do not receive a confirmation email within forty-eight (48) hours of submitting, follow the instructions in Section E.3.

F. Application Review Information

F.1. Responsiveness Review

The Responsiveness Review, also called a “threshold” review, is a preliminary review that determines whether an application meets specified completion and eligibility levels. During this phase, each application will be reviewed for completion and eligibility, as defined in Section B. Eligibility. Budgets will be reviewed to ensure costs are allowable, reasonable, and linked to the described objectives in Section C. Program Description.

All applicants who have submitted applications that are determined to be noncompliant or ineligible will be notified by email, upon determination. This email will be sent to the email addresses the applicant provides in the application and will identify the reason for disqualification.

 

F.2. Grant Funds Use Requirements

All awarded applicants shall use grant funds according to the guidelines, conditions, and parameters set forth in this funding notice and in compliance with federal and state statutes, regulations, policies, and the terms and conditions of the subaward agreement.

State and Federal Laws or Regulations

In addition to the statutes and regulations listed in Section C.6. Authorizing Statutes and Regulations, every entity that is awarded funds through this NOFO must agree to comply with all applicable provisions of state and federal laws and regulations pertaining to nondiscrimination, sexual harassment, and equal employment opportunity, including but not limited to the following:

  • The Illinois Human Rights Act (775 ILCS 5/)
  • The Public Works Employment Discrimination Act (775 ILCS 10/)
  • The U.S. Civil Rights Act of 1964 (as amended) (42 USC 2000a, et seq.)
  • Section 504 of the Rehabilitation Act of 1973 (29 USC 794)
  • The Americans with Disabilities Act of 1990 (as amended) (42 USC 12101 et seq.)
  • The Age Discrimination Act of 1975 (42 USC 6101–6107)

Additionally, the entity must comply with the following:

  • 45 CFR Parts 93 and 94
  • The Adult Protective Services Act, 320 ILCS 20/

Compliance with Funding Sources and Other Statutes

The agency awarded funds shall act in accordance with all conditions related to the relevant funding sources outlined in the following:

  • Illinois Cannabis Regulation and Tax Act (410 ILCS 705/)
  • Applicable regulatory requirements, such as the Illinois Substance Use Disorder Act (20 ILCS 301/)
  • Any other relevant state statutes

Third-Party Contractual Requirements

Any third-party contracts paid for using grant funds are subject to GATA requirements and the terms and conditions of the subaward. The subrecipient is required to include certain subaward agreement language in their subrecipient or contractor agreements and provide those agreements to the RCCA. Lower-tier subrecipient and contractor agreement(s) and budgets must be preapproved by the RCCA, but the RCCA does not have privity of contact with those parties. The subrecipient shall retain sole responsibility regarding the performance and monitoring of the lower-tier subrecipient(s) and contractor(s).

Religious/Sectarian Prohibitions

Funds shall not be used for inherently religious activities, such as worship, religious or sectarian instruction, or proselytizing. If the applicant is a faith-based or a religious organization that offers such activities, these activities shall be voluntary for the individuals receiving services and offered separately from the program. Religious organizations as defined under 42 CFR 54.2(b) shall comply with the Charitable Choice Regulations as set forth in 42 CFR 54.1 et seq. No organization shall, on the grounds of gender (including in the case of any woman due to pregnancy) or of religion, exclude any patient from participation in, or deny the benefits of any services or activities funded with these subaward funds.

F.3. Review Criteria

The scoring will be based on need, as described in Sections C.2. and C.3. above; capacity; quality of the organization’s work; and other grant-specific criteria. Points available are detailed in Section D.1. Contents and Point Distribution, and associated questions are available on the Prepare to Apply page.

 

F.4. Review and Selection Process

Merit-Based Review

All competitive grant applications are subject to merit-based review in accordance with 44 Ill. Admin. Code Sec. 7000.350. A clear description of each criterion and subcriterion is found with the application questions on the Prepare to Apply page.

An applicant will only be accepted for a merit-based review upon meeting the eligibility criteria stated in Section B Eligibility.

Evaluation Committee

Evaluation of the application will be conducted by a review committee comprising a minimum of three (3) individuals with relevant subject matter expertise, including persons with lived experience. The committee is involved in the deliberative process and independently and confidentially reviews applications and assigns a numerical rating to the application questions. The scoring tool scores the evaluation criteria based on funding priorities and the point allocations for each section of the application.

Please note: Evaluation committee members will not have any actual or apparent conflicts of interest.

RCCA leadership will compile the review committee scores, facilitate communication with the review committee on any variances, document any revisions, weigh funding priority criteria, and verify that applicants have completed all prequalification and pre-award requirements. The RCCA will then present recommendations of award finalists to IDHS/DBHR staff.

Finalist Recommendations

While the recommendation of the merit-based review panel will be a key factor in the funding decision, the RCCA maintains final authority over funding decisions and considers the findings of the reviewers to be advisory, nonbinding recommendations. The numerical score may not be the sole award criterion. The RCCA reserves the right to consider other factors, such as geographic distribution, demonstrated need, and agency past performance as a State grantee as described in Sections C.2. and C.3. Any internal documentation used in scoring or awarding of grants shall not be considered public information.

In the event of a tie, and funding is insufficient to select all tied applications, the RCCA may choose one of the following options:

  • Apply one (1) or more of the additional factors for consideration described above to prioritize the applications
  • Partially fund each of the tied applications
  • Not fund any of the tied applications

Appeal

Competitive grant appeals are limited to the evaluation process. Evaluation scores may not be protested. Only the evaluation process is subject to appeal. If appealed, the evaluation process shall be reviewed by the RCCA’s Appeal Review Officer (ARO).

Appeal decisions are final.

Submission

Appeals submission contact information:

  • Name of agency contact for appeals: Regional Care Coordination Agency
  • Email address of agency contact for appeals: [email protected]
  • Email subject line: NOFO Review Appeal

An appeal must be submitted in writing to the appeals submission contact listed above. An appeal must be received within fourteen (14) days after the date that the grant award notice has been published.

The written appeal shall include, at a minimum, the following:

  • Name and address of the appealing party
  • Identification of the grant
  • Statement of reasons for the appeal
  • Supporting documentation, if applicable

Response

The RCCA will acknowledge receipt of an appeal within fourteen (14) days from the date the appeal was received.

  • The RCCA will respond to the appeal within sixty (60) days or supply a written explanation to the appealing party of why additional time is needed.
  • The appealing party must supply any additional information requested by the Appeal Review Officer (ARO) within the time the ARO sets in their request.

Resolution

The ARO shall make a recommendation to the RCCA Project Director or designee as expeditiously as possible after reviewing all relevant information.

  • In determining the appropriate recommendation, the ARO shall consider the integrity of the competitive grant process and the impact of the recommendation on the RCCA.
  • The RCCA will resolve the appeal by means of written determination.
  • The determination shall include: review of the appeal, appeal determination, and rationale for the determination.

F.5. Risk Review

Under 2 CFR § 200.332, the RCCA must evaluate each subrecipient’s risk of noncompliance with federal or state statutes, regulations, and the terms and conditions of the subaward for purposes of determining the appropriate subrecipient monitoring. These possible conditions are included in the NOIA and are described in Section H.1. Award-Specific Conditions. The pre-award process includes establishing a risk profile through risk assessment of the organization’s

  • Financial stability,
  • Management systems and standards,
  • History of performance,
  • Audit reports and findings, and
  • Ability to implement requirements of the award.

This risk assessment is carried out with the aid of the following information:

  • Administrative, fiscal, and internal controls information entered in Sections 1–2 of the Online Application
  • Organizational and programmatic information detailed in Attachments B, C, and E

The RCCA may also request additional information during the pre-award process.

Please note: Risk assessments do not necessarily preclude entities from becoming grantees. Risk assessments are used to identify subrecipient TTA needs and if specific conditions are needed.

Additional risk review involves the following:

  • Because this grant is not a simplified acquisition procurement, prior to making a subaward, the RCCA is required to review and consider any information about the applicant that is in the responsibility/performance records available in SAM.gov.
  • An applicant, at its option, may review and comment on its information in the responsibility/performance section of SAM.gov.
  • The RCCA will consider any comments by the applicant and other information in the responsibility/performance section of SAM.gov before making decisions in the risk review.

G. Award Notices

G.1. Anticipated Announcement of Award

The announcement of this award is anticipated by February 18, 2027.

G.2. Notice of Intent to Award

PLEASE NOTE: The NOIA does not constitute a contract or an agreement to receive grant funds and is NOT an authorization to begin performance on the program. Execution of the subaward agreement by both parties is the authorizing document and that agreement indicates when the subrecipient’s performance can begin.

Applicants recommended for funding following the review process and budget approval will receive a Notice of Intent to Award via email to the contacts identified in the application. The NOIA shall include the grant award amount, the terms and conditions of the award, and specific conditions, if any, assigned to the applicant based on risk assessments and merit-based review.

PLEASE NOTE: The initial budget submitted at the time of application might not be approved due to unallowable costs, errors in budget, or a difference between requested award amount and approved final award amount. The RCCA will inform the organization’s point of contact if the proposed budget is rejected.

Upon receipt of the NOIA, selected applicants shall review and make an informed decision about their capacity to perform under the requirements of the subaward and whether to accept the funds. The NOIA must be signed by the applicant’s grants officer (or equivalent). This signature indicates agreement with the award amount and the conditions set forth within the notice. This signed NOIA is a document that informs the RCCA to proceed with issuing the subaward agreement. Please be advised that your selection is conditional until the subaward agreement is signed by both authorizing parties. The signed NOIA must be remitted to the RCCA, as instructed in the NOIA.

The NOIA is not an authorization to begin performance. The period of performance begins on the effective date of the subaward agreement.

Applicants not receiving this award will be notified with a Notice of Non-Award letter via email, which will be sent to the contacts identified in the application at the same time the NOIA letters are sent.

G.3. Pre-Award Costs

Pre-award costs are not allowed. Beginning performance prior to the execution of the subaward agreement is at the applicant’s risk and expense.

 

G.4. Subaward Agreement

Upon receipt of acceptance of award, the RCCA will initiate the development of the subaward agreement and the SOW. The Subaward Agreement and the SOW attachment will include the following information: activities to be performed, time schedule, applicable policies and requirements, the terms and conditions of the Subaward Agreement, and the dollar limitation of the agreement.

A review copy, in Microsoft Word format, of the subaward agreement will be distributed to organizational and application contacts designated in the application. Upon completion of any negotiations, the designated signatory will receive an email notification that the agreement is ready for review and electronic signature via a system called Ironclad. The signed subaward agreement shall be returned to the RCCA as prescribed.

G.5. Payment Terms

Payments will be in accordance with 2 CFR Part 200 and 44 Ill. Admin. Code Sec. 7000.120. Three different award payment methods exist: Advance Payment, Reimbursement, and Working Capital Advance.

Advance Payment Method (Advance and Reconcile)

Budgets must be signed by either the Chief Executive Officer (or equivalent) or Chief Financial Officer (or equivalent) for the entity. The executive’s signature certifies that their entity complies with the requirements set forth in 2 CFR 200.302 (Financial Management) and 44 Ill. Admin. Code 7000.120(b)(1) (Advance Payments). The Cash Budget must demonstrate the estimated monthly cash requirements for each month of program Award operation. Advance payments to a subrecipient must be limited to the minimum amounts needed and be timed with actual, immediate cash requirements of the subrecipient in carrying out the purpose of the approved program. The timing and amount of advance payments must be as close as is administratively feasible to the actual disbursements by the subrecipient for direct program or project costs and the proportionate share of any allowable indirect costs. The subrecipient must make timely payments to contractors or lower tier subrecipients in accordance with the subaward agreement provisions 2 CFR § 200.305.

If the Advance Payment Method is approved, an initial payment will be processed in an amount equal to the first two (2) months’ cash requirements as reflected in the submitted Advance Payment Requirements Forecast (Cash Budget) Form. To receive the advance payment, the subrecipient must maintain or demonstrate the willingness to maintain both written procedures that minimize the time elapsing between the transfer of funds and disbursement by the subrecipient, and financial management systems that meet the standards for fund control and accountability as established in 2 CFR Part 200.

Subrecipients must submit monthly invoices in the format and method prescribed in the executed Subaward Agreement. The first invoice is due after the first month of grant operations. Invoices must include only allowable incurred costs that have been paid by the subrecipient.

Subsequent monthly payments will be based on each monthly invoice submitted to the program and will be adjusted up or down based on a comparison of actual cumulative expenditures to cumulative advance payments to date.

Subrecipients that do not spend all advance payment amounts by the end of the grant term or that cannot demonstrate that all incurred costs were necessary, reasonable, allowable, or allocable as approved in their respective grant budget must return the funds within forty-five (45) days or be subject to grant funds recovery.

Subrecipients may be required to submit supporting documentation for their advance requests at the request of and in a manner prescribed by the RCCA.

Failure to abide by advance payment governance requirements may result in the subrecipient losing their right to advance payments.

Reimbursement Method

The reimbursement method will be used when subrecipients do not meet the requirements of 44 Ill. Admin. Code Sec. 7000.120(b)(1), upon a subrecipient’s request to use the reimbursement method of payment, or as stipulated in a specific condition pursuant to 2 CFR § 200.208. See 44 Ill. Admin. Code 7000.120(b)(2). Subrecipients that have specific conditions noted in their NOIA or Subaward Agreement for any of the following items must be paid using the reimbursement method:

  • Fiscal and administrative high risk (weak internal controls)
  • A history of failure to comply with general or specific terms and conditions of grant awards
  • Failure to meet expected performance goals as described in 2 CFR § 200.211 or to attain their program deliverables as stated in their applicable Subaward Agreement
  • Otherwise warranted by the risk assessment and/or findings in government databases (e.g., SAM.gov)

The RCCA will disburse payments to the subrecipient based on actual allowable costs incurred as reported in the monthly financial invoice submitted for the respective month, as described below.

Subrecipients must submit monthly invoices in a format prescribed by the RCCA and as required in the Subaward Agreement. Invoices must include all allowable incurred costs for the first and each subsequent month of operations until the end of the grant term. Invoices shall be submitted to the RCCA on or before the fifteenth (15th) day following the end of any respective monthly invoice period. As practicable, the RCCA will process all payments to ensure that payments can be made (subject to appropriation, cash availability, and processing by the Office of the Comptroller) within thirty (30) days after receipt of the invoice, unless the RCCA reasonably believes the request to be improper.

Working Capital Advance Method

For subrecipients that cannot meet the requirements set forth in 2 CFR 200.305(b) (describing advance payments), 2 CFR § 200.302 (Financial Management), 44 Ill. Admin. Code Sec. 7000.120(b)(1)(A)(i and ii) (Advance Payments), and other applicable requirements, and if the RCCA determines that reimbursement is not feasible because the subrecipient lacks sufficient working capital, the RCCA may, in its sole discretion, provide a working capital advance to the subrecipient.

Subrecipients may request separate working capital advance payments for each grant program awarded by the RCCA. Requests must be submitted to the RCCA on the Advance Payment Request Cash Budget tab within the Budget Workbook (Cash Budget). The Cash Budget must include monthly cash requirements for every month of the grant term. A separate request must be submitted for each grant program application. The chief executive officer (or equivalent) or the chief financial officer (or equivalent) for the subrecipient entity must attest upon award that the cash requirements are actual expected costs.

If approved, the RCCA will advance working capital payments to the subrecipient to cover their estimated disbursement needs for an initial period not to exceed two (2) months of grant expenses. Startup costs may be approved if determined by the RCCA to be allowable.

  • Subrecipients must submit monthly invoices for each of the one (1) or two (2) months covered by the Working Capital Advance in the format and method prescribed in the subrecipient’s executed Subaward Agreement Exhibits. The first invoice is due after the first month of grant operations. Invoices must include only allowable incurred costs that have been paid by the subrecipient.
  • Subrecipients may be required to submit supporting documentation for their requests at the request of and in a manner prescribed by the RCCA.
  • Working Capital Advance Payments are limited to a single occurrence per grant term.
  • Following the initial period, the RCCA will reimburse the grantee for its actual cash disbursements as described in the Reimbursement Method section above.

H. Post-award Requirements and Administration

Successful applicants agree to provide program services as described throughout this funding notice.

H.1. Award-Specific Conditions

Per 2 CFR § 200.332(c) and (d), the RCCA must evaluate each applicant’s risk of noncompliance and consider imposing additional specific award conditions as needed. RCCA’s risk analysis considers the following factors:

  • The subrecipient’s past experience with and performance on the same or similar awards, including when an applicant or recipient has a history of failure to comply with the general or specific terms and conditions of a state or federal award or has failed to meet expected performance goals
  • The results of previous audits
  • Whether the subrecipient has new personnel or new or substantially changed systems
  • The extent and results of any Federal or state agency monitoring
  • Other criteria set forth in 2 CFR § 200.206

Under 2 CFR § 200.208, these conditions may include items such as the following:

  • Requiring payments as reimbursements rather than advance payments
  • Withholding authority to proceed to the next phase until receipt of evidence of acceptable performance
  • Requiring additional or more detailed financial reports
  • Requiring additional program monitoring
  • Requiring the recipient or subrecipient to obtain technical or management assistance
  • Establishing additional prior approvals

More restrictive conditions may be imposed based upon the criteria set forth in 44 Ill. Admin. Code Sec. 7000.340.

In response to a subrecipient’s request, the RCCA will promptly remove the specific conditions once it has determined that issues have been corrected.

H.2. Start Date

Applicants must be prepared to begin grant activities starting April 1, 2027, subject to funding availability and other award execution considerations.

 

H.3. Site Visits

The applicant agrees to authorize access to its facilities and records and to participate in site visits/quality reviews as requested by the RCCA.

 

H.4. Technology

Agencies awarded funds through this funding notice shall have a computer that meets the following minimum specifications for the purpose of using any required web-based reporting system and the receipt/submission of the electronic program and fiscal information:

  • Internet access, preferably high-speed
  • Email capability
  • Microsoft Excel
  • Microsoft Word
  • Microsoft PowerPoint
  • Webex
  • Adobe Acrobat Reader

The purchase of this technology would be an allowable expenditure under the grant and may be included in the budget as part of this application.

H.5. Hiring and Employment Policy

The RCCA encourages cultural diversity in the work environment and to promote employment opportunities through its programs. The program workforce shall appropriately reflect the populations to be served, with special attention given to hiring individuals indigenous to those communities. Whenever a position becomes available, funded programs are encouraged to consider employing individuals who receive Temporary Assistance for Needy Families, contingent upon their qualifications (i.e., education and work experience).

 

H.6. COVID-19 Policies and Procedures

Applicant shall have written COVID-19 policies and procedures that align with current guidelines from their local health department, IDPH, and/or the Centers for Disease Control and Prevention.

 

H.7. Publication of Studies, Reports, and Other Program Products

The applicant agrees that products produced for the RCCA under this award, including but not limited to research reports, data, analyses, and policy recommendations, are the property of the RCCA and will not be published or distributed except as prescribed by the RCCA.

 

H.8. Administrative and National/State Policy Requirements

The agency awarded funds shall provide services as set forth in the Subaward Agreement and shall act in accordance with all state and federal statutes and administrative rules applicable to the provision of the services. The subaward agreement will be modeled on the IDHS FY27 Grant Agreement and Division of Behavioral Health and Recovery Substance Use and Gambling Disorder Services Attachment C. Additional terms and conditions not specified herein may apply.

 

H.9. Uniform Guidance (2 CFR § 200, et al.) Requirement Revision, Effective October 1, 2024

§ 200.113 Mandatory disclosures

“An applicant, recipient, or subrecipient […] must promptly disclose whenever, in connection with the […] award (including any activities or subawards thereunder), it has credible evidence of the commission of a violation of Federal criminal law involving fraud, conflict of interest, bribery, or gratuity violations found in Title 18 of the United States Code or a violation of the civil False Claims Act (31 U.S.C. 3729–3733).” The disclosure must be made in writing to IDHS, the agency’s Office of Inspector General, and pass-through entity RCCA (if applicable). “Recipients and subrecipients are also required to report matters related to recipient integrity and performance in accordance with Appendix XII of this part. Failure to make required disclosures can result in any of the remedies described in § 200.339. (See also 2 CFR part 180, 31 U.S.C. 3321, and 41 U.S.C. 2313.)” 2 CFR § 200.113.

 

H.10. Reporting and Grants Administration Requirements

Subrecipients shall comply with any and all federal and state reporting requirements. Reports shall be submitted electronically as prescribed by the RCCA.

Upon execution of the Subaward Agreement, subrecipients shall fulfill the requirements outlined below. Additional periodic and annual performance and evaluation data may be collected as directed by the RCCA and in a format prescribed by the RCCA.

Kickoff Meeting

Subrecipient shall attend a virtual Kickoff Meeting, hosted by AHP, no later than thirty (30) days from the commencement of the period of performance. The meeting shall be attended by, at a minimum, the Program Director and at least one additional program staff.

Implementation and Sustainability Plan (ISP)

Subrecipient shall submit an ISP using the current RCCA-provided template no later than ninety (90) days from the commencement of the period of performance. The ISP is the program plan describing how the Subrecipient will deliver the program: service model, infrastructure, staffing, local needs, partnerships, and Equity and Racial Justice (ERJ) approach. It is supported by an ISP Data Workbook that establishes the approved delivery and performance baseline, including what will be delivered, in what volume, and how performance will be measured. Upon RCCA approval, the ISP Data Workbook becomes the performance baseline for all delivery standards. Subrecipient shall incorporate any RCCA-required revisions within fifteen (15) days of RCCA feedback, and shall submit an ISP amendment for a material change; routine operational updates are reported through the PPR.

Equity and Racial Justice (ERJ) Plan

Subrecipient shall complete the Equity and Racial Justice (ERJ) self-assessment and preliminary equity approach as part of the ISP, submit a complete ERJ Plan no later than one hundred eighty (180) days from the commencement of the period of performance, and incorporate any RCCA-required revisions within fifteen (15) days of RCCA feedback.

Periodic Performance Reports (PPR)

Subrecipient shall electronically submit the PPR to AHP no later than the twentieth (20th) day after each State Fiscal Year quarter ends. Quarters end September 30, December 31, March 31, and June 30. The PPR is an 8-section workbook covering activity data, outcome measures, milestones, program status, ERJ update, sustainability progress, continuous improvement, and fiscal summary.

Delivery and Performance Report (DPR)

Subrecipient shall submit the DPR via Qualtrics. The DPR is submitted monthly, no later than the 15th following the close of the reporting period.

Financial Reports (Invoices)

Subrecipient shall submit monthly Financial Reports (Invoices) in the RCCA-prescribed format no later than the fifteenth (15th) day of the month following each reporting month. The monthly Invoice also serves as the payment request.

Periodic Financial Reporting

Subrecipient shall electronically submit the PFR to AHP no later than the twentieth (20th) day after each State Fiscal Year quarter ends. The PFR shall detail the expenditures of the subaward using a template or platform provided by AHP.

Training and Technical Assistance (TTA)

Subrecipient shall participate in a minimum of seventy-five percent (75%) of scheduled TTA activities, including onboarding TTA sessions (up to three (3)), cohort-focused TTA as scheduled (up to quarterly), and additional TTA based on performance needs or request.

Project Status Meetings (PSMs)

Subrecipient program leadership shall participate in RCCA-scheduled PSMs quarterly, with a minimum of seventy-five percent (75%) participation.

Program-Specific Evaluation Reporting

Project Staffing

Subrecipient shall submit an organizational chart with all budgeted positions, FTE allocations, and reporting lines no later than sixty (60) days from the commencement of the period of performance, and shall maintain staffing at no less than eighty percent (80%) of the approved staffing plan, including designated program leadership, throughout the period of performance.

Closeout

Subrecipient shall submit the Performance Close-out Report no later than thirty (30) calendar days after the period of performance ends, and the Financial Close-out Report and Final Invoice no later than forty-five (45) calendar days after the period of performance ends, with all obligations liquidated within the same period.

H.11. Monitoring

Subrecipients funded through this NOFO are subject to fiscal and programmatic monitoring in accordance with 2 CFR § 200.332. Subrecipients shall provide the RCCA access to subaward records pursuant to 2 CFR § 200.337 and 44 Ill. Admin. Code 7000.430.

 

H.12. Awarding Agency Contacts

For information about this NOFO, submit questions through the OTPP-3 Applicant Contact Form.

 

I. Other Information

List of Acronyms

The following acronyms are used throughout this funding notice.

Acronym Definition
AHP Advocates for Human Potential, Inc.
ARO Appeal Review Officer
ASAM American Society of Addiction Medicine
AUD Alcohol use disorder
DBHR Division of Behavioral Health and Recovery
DEA Drug Enforcement Administration
DPR Delivery and Performance Report
EHR Electronic health record
ERJ Equity and Racial Justice
FDA Food and Drug Administration
FEIN Federal Employer Identification Number
FQHC Federally qualified health center
FTE Full-Time Equivalent
GATA Grant Accountability and Transparency Act
ICQ Internal Controls Questionnaire
IDHS Illinois Department of Human Services
IDPH Illinois Department of Public Health
IM Intramuscular
ISP Implementation and Sustainability Plan
MAR Medication-assisted recovery
MOU Memorandum of understanding
MOUD Medications for opioid use disorder
MTDC Modified Total Direct Cost
NICRA Negotiated Indirect Cost Rate Agreement
NOFO Notice of Funding Opportunity
NOIA Notice of Intent to Award
ONC Office of the National Coordinator for Health Information Technology
OOSA Office of Opioid Settlement Administration
OTP Opioid treatment program
OTPP Opioid Treatment Program Partnerships
OUD Opioid use disorder
PFR Periodic Financial Report
PPR Periodic Performance Report
PSM Project Status Meeting
RCCA Regional Care Coordination Agency
SAMHSA Substance Abuse and Mental Health Services Administration
SOW Statement of Work
SUD Substance Use Disorder
TBH To Be Hired
TTA Training and Technical Assistance
UEI Unique Entity Identifier

I.1. Obligation of Award

The release of this NOFO does not obligate the RCCA to make an award. The RCCA reserves the right to negotiate with successful applicants to adjust award amounts, targets, deliverables, etc. These negotiations do not obligate the provision of funding, nor should an applicant draw any conclusions from these negotiations about the RCCA’s intentions to fund or not fund the proposed grant award.

 

I.2. Definitions

Collaborative Medical and Behavioral Health Care. Medical and behavioral health services delivered by the Subrecipient and its medical partner(s) under the approved MOU and under the direction of the Program Director, including screening, assessment, examination, treatment, counseling, health education, peer support, and social services intended to help patients receiving care in the OTP achieve and sustain remission and recovery.

Community Relations Plan. The Subrecipient’s plan for engaging the community surrounding an OTP or satellite location, identifying community leaders, points of contact within the OTP and the community, communications protocols, and opportunities for paid work experiences that expand the local workforce.

Coordination of Services. Regular case conferences or other structured methods, held in person or virtually, through which the Subrecipient and its medical partner(s) coordinate care for OTP patients.

Dispense. To deliver a controlled medication to an ultimate user by, or pursuant to, the lawful order of, a practitioner, including the prescribing and administering of a controlled medication (42 CFR § 8.2).

Diversion Control Plan. A set of documented procedures, maintained as part of the Subrecipient’s quality assurance program, that reduce the possibility that controlled medications will be transferred or otherwise shared with a person to whom the medication was not prescribed or dispensed, and that assign responsibility for each control measure to named OTP clinical and administrative roles.

Federally Qualified Health Center (FQHC). A federally funded nonprofit health center or clinic serving medically underserved areas and populations, providing primary care services regardless of ability to pay.

Harm Reduction. A practical and transformative approach that incorporates community-driven public health strategies, including prevention, risk reduction, and health promotion, to empower people who use drugs and their families with the choice to live healthier, self-directed, and purpose-filled lives. Harm reduction centers the lived and living experience of people who use drugs, especially those in underserved communities, in these strategies and the practices that flow from them.

Low-barrier Access. Delivery of MAR that minimizes conditions on entry to treatment, under which same-day admission and medication access is preferred, services to high-risk groups are expedited, and access to MOUD is not conditioned on participation in counseling.

MAR Desert. A region not adequately served by an existing opioid treatment program or medication unit, including counties in which no MAR provider operates.

Medical Director. A physician licensed to practice medicine in Illinois who assumes responsibility for all medical and behavioral health services provided by the OTP, including their administration. The Medical Director may delegate specific responsibilities to authorized program physicians or to appropriately licensed or credentialed practitioners under the Medical Director’s supervision, but delegation does not relieve the Medical Director of responsibility.

Medical Partner. A federally qualified health center, hospital, clinic, or public department of health with which the Subrecipient maintains an MOU or partnership agreement for the delivery of collaborative medical and behavioral health care to OTP patients.

Medication Unit. A satellite location of an existing opioid treatment program at which medications for opioid use disorder are administered or dispensed under the OTP’s certification.

Medication-Assisted Recovery (MAR). The use of FDA-approved medications for the treatment of opioid use disorder (OUD) and alcohol use disorder (AUD).

MOUD. Medications for opioid use disorder: the FDA-approved medications dispensed or administered for the treatment of OUD.

New Partnership. A partnership between an OTP and a medical partner under which the OTP had no memorandum of understanding or partnership agreement with that medical partner on November 18, 2026.

Opioid Treatment Program (OTP). A provider of medication-assisted treatment for people diagnosed with an opioid use disorder. OTPs must be certified by SAMHSA and accredited by an independent, SAMHSA-approved accrediting body.

Patient Admission Criteria. The Subrecipient’s policies and procedures governing admission to MAR, identifying the personnel qualified to determine that a patient meets diagnostic criteria and setting out the requirements for informed consent to treatment.

Program Sponsor. The person named in the application for OTP certification as responsible for the operation of the OTP and for all its employees, including practitioners, agents, and other persons providing medical, behavioral health, or social services at the program or any of its medication units. The Program Sponsor need not be a licensed physician but shall ensure that an actively licensed physician occupies the position of Medical Director.

Recovery Support Services. Services including community-based recovery housing, peer recovery support, social support, and linkage to and coordination among allied service providers, that extend the continuum of care by strengthening and complementing substance use disorder treatment interventions across settings and stages (42 CFR § 8.2).

Warm Handoff. An active, participant-present transfer connecting an individual to harm reduction, recovery support, or other services. Providing contact information without an active transfer does not qualify.

 

I.3. Applicant Technical Assistance

Prequalification and Pre-award Resources

IDHS Pre-Qualification Instructions and Resources provide helpful information about the completion of prequalification and pre-award activities.

Technical Assistance Session

Attend or listen to the technical assistance session (recommended, but not required) at the Illinois RCCA website.

Submit Questions and Review Answers

Submit questions through the OTPP-3 Applicant Contact Form no later than January 4, 2027, at 5:00 p.m. CT.

 

J. Mandatory Forms

J.1. Budget Workbook

Subrecipients must use the Budget Workbook Template to submit their program budget and advance payment request. The Workbook file is available at the IL RCCA website.

The budget and narrative must tie fiscal activity to program objectives and deliverables and must demonstrate that all proposed costs are reasonable and necessary, allocable, and allowable as defined by program regulatory requirements and Uniform Guidance (2 CFR Part 200, Subpart E), as applicable.

Verification of final approved budgets will be required by either the chief executive officer (or equivalent) or chief financial officer (or equivalent) for the entity. The executive must certify that their entity complies with the requirements set forth in 2 CFR § 200.302 (Financial Management) and 44 Ill. Admin. Code 7000.120(b)(i) (Advance Payments).

J.2. Conflict of Interest and Financial Disclosures

Subrecipients must immediately disclose in writing to the RCCA any actual or potential conflict of interest as soon as it becomes known, in accordance with 30 ILCS 708/35, 30 ILCS 708/60(a)(5), 44 Ill. Admin. Code Sections 7000.30 and 7000.330(f) and 2 CFR 200.113, and the subaward agreement. This disclosure must be submitted by all subrecipients, whenever an actual or potential conflict may exist. The Grantee Conflict of Interest Disclosure form is available for download from the IDHS website.

Financial or Other Interests

Subrecipients have a continuing obligation to disclose to the RCCA financial or other interests (public, private, direct, or indirect) that may be a potential conflict of interest or could prohibit the subrecipient from entering or continuing the programs for which the grant is intended.

 

K. References

Legislative and Regulatory References

Code of Federal Regulations

  • 2 CFR Part 200 – Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards
  • 34 CFR Part 77 – Department of Education Regulations
  • 42 CFR Part 8 – Medications for the Treatment of Opioid Use Disorder
  • 42 CFR Part 54 – Charitable Choice Regulations

Illinois Administrative Code

Illinois Compiled Statutes

Program-Specific References

  • CARF International. Community Relations Tips for Opioid Treatment Programs.
  • Substance Abuse and Mental Health Services Administration (SAMHSA). Opioid Treatment Program Directory.

Program Research and Data Sources

  • American College of Obstetricians and Gynecologists. (2017). Opioid use and opioid use disorder in pregnancy (Committee Opinion No. 711). Obstetrics & Gynecology, 130, e81–e94.
  • Centers for Disease Control and Prevention. (n.d.). Opioid use disorder: Treating. Overdose Prevention. https://www.cdc.gov/overdose-prevention/hcp/clinical-care/opioid-use-disorder-treating.html
  • D’Arrigo, T. (2019). Stigma, misunderstanding among the barriers to MAT treatment. Psychiatric News, 54(19). https://doi.org/10.1176/appi.pn.2019.10a2
  • Timko, C., Schultz, N. R., Cucciare, M. A., Vittorio, L., & Garrison-Diehn, C. (2016). Retention in medication-assisted treatment for opiate dependence: A systematic review. Journal of Addictive Diseases, 35(1), 22–35. https://doi.org/10.1080/10550887.2016.1100960
  • Wakeman, S. E., Larochelle, M. R., Ameli, O., et al. (2020). Comparative effectiveness of different treatment pathways for opioid use disorder. JAMA Network Open, 3(2), e1920622. https://doi.org/10.1001/jamanetworkopen.2019.20622